Prevalence of Extended Spectrum Beta Lactamases (ESBL) Producing Escherichia coli and Klebsiella pneumoniae in Tuberculosis Patients in Kano, Nigeria

Abstract

Resistance to broad spectrum β lactams, mediated by extended spectrum beta lactamase (ESβL) is an increasing problem worldwide. Production of these enzymes in clinical infections can result in treatment failure if one of the second or third generation cephalosporins is used. This study investigates the incidence of ESBL among E. col i and K. pneumoniae which were isolated from tuberculosis patients with secondary opportunistic bacterial infection attending Aminu Kano Teaching Hospital (AKTH), Kano and Infectious Disease Hospital (IDH), Kano. A total of 37 E. coli and 33 K. pneumoniae obtained from their sputum were screened for ESBL production by Double disk synergy test method (DDST). Prevalence of 37.3% (14/37) and 36.4% (12/33) was recorded for Escherichia coli and Klebsiella pneumoniae respectively. Furthermore, a slight high prevalence of 39.4% (13/33) was recorded with the female tuberculosis patients when compared with their male counterpart 35.1% (13/37). Escherichia coli harboring ESBL were more encountered among the elderly patients aged 31-50 (13/51 or 25.5%) when compared with K. pneumoniae with (9/51 or 17.6%). The study shows alarming rise in ESBL production among Klebsiella pneumoniae and Escherichia coli among immunocompromised patients raising fear of possible emergence of multiple drug resistant bacteria that will be hard to treat. Thereby early detection of ESBL in these patients is recommended to curb the spread. Keywords: Extended spectrum beta lactamase (ESBLs), Escherichia coli, Klebsiella pneumoniae, Tuberculosis.